Investment

Biotech Company Gameto Adds $17M in Funding to Develop Therapeutics for Diseases in the Female Reproductive System

Gameto, a biotech company using cell engineering to develop therapeutics for diseases of the female reproductive system, has added $17M in funding from Insight Partners, Future Ventures, Arcadia Investment Partners, Bold Capital Partners, Plum Alley, Myelin VC, TA Ventures, Gaingels, Korify Capital, and other existing investors. The new financing brings the total capital raised since inception to $40M. Gameto’s last funding round was announced…

AOA Dx Adds $4.5M in Seed Funding to Develop the Next Generation of Its Ovarian Cancer Detection Technology

In June 2021 AOA Dx rasied $2.5M in seed funding after having participated in Y Combinator’s 2021 summer cohort. Yesterday the company announced another funding round, which now brings total funding to $7M. Participants in the latest round include Avestria Ventures, AlleyCorp, The Helm, RH Capital, Olive Tree Capital, Tencent. The new funds will be used to further develop the next generation…

Transdermal Diagnostics Picks Up £1.1M for Its Needle-free Continuous Glucose Monitor

Transdermal Diagnostics, a University of Bath spinout company developing technology to monitor glucose levels non-invasively, has received £800K in seed funding and a £300K grant from Innovate UK. The seed round was led by QUBIS, which specialises in innovation focused spin-out companies, and includes Pioneer Group, Immetric, Bristol Private Equity Club and Science Angel Syndicate. In March 2022, the researchers – led…

Millie Picks Up $4M in Seed Funding to Raise the Bar for Maternity Care in the U.S.

According to findings from The Commonwealth Fund show that American women have the highest death rate from complications of pregnancy and childbirth, which is more than double the rates of most other high-income countries. Additionally, a 2019 study found that annual maternal morbidity from conception through age 5 resulted in a projected cost of $32.2 billion. Improving these outcomes is a key focus for…

UK-based CBD Lifestyle Brand TRIP Adds $12M in Funding to Support the Company’s International Expansion

UK-based CBD lifestyle brand TRIP has raised $12M to support the brand’s international growth. Investors in the round include prominent entrepreneurs, business leaders and investors, including Maria Raga, the former CEO of Depop, and Christian Angermayer, Founder of Apeiron Investment Group. Known in the UK as the “Queen’s CBD,” having received the royal seal of approval by selling out of the Queen’s Windsor shop, TRIP was founded by…

Virtual Fertility Clinic Apricity Raises €17M in Series B Funding to Support International Expansion

Apricity, the UK’s leading virtual fertility clinic has raised €17M in Series B funding to support the companies expansion in Europe. The round was led by MTIP, a Swiss healthtech fund with participation from Spain-based consumer fund Iris Ventures. Apricity launched in 2018 in the UK and was originally incubated by Kamet Ventures. The company advocates for a new approach to reproductive…

Plume Adds $24M in Series B Funding to Expand Its Gender-Affirming Virtual Care Services in the U.S.

Plume provides virtual care services purposefully designed for the health care needs of the transgender community and has now raised a $24M Series B Funding Round led by Transformation Capital. Other investors participating in the round include General Catalyst and Townhall Ventures. The growth investment in Plume will support the company in fulfilling its mission to transform health care for every trans…

Hera Biotech Raises $1.9M in Seed Funding for Its Non-surgical Diagnostic Test for Endometriosis

Medical device start-up Hera Biotech has raised $1.9M in seed funding to support the commercialization of MetriDx, the company’s non-surgical diagnostic test for endometriosis. Investors in this round include Coyote Ventures, Stella Angels, Althea Group Ventures, and the Kendra Scott Women’s Entrepreneurial Leadership Institute. Hera Biotech plans to use the new funds to complete an in-patient human clinical study, expand its IP portfolio, and…